Label-free macrophage phenotype classification using machine learning methods.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 03 2023
Historique:
received: 09 10 2022
accepted: 23 03 2023
medline: 3 4 2023
entrez: 30 3 2023
pubmed: 31 3 2023
Statut: epublish

Résumé

Macrophages are heterogeneous innate immune cells that are functionally shaped by their surrounding microenvironment. Diverse macrophage populations have multifaceted differences related to their morphology, metabolism, expressed markers, and functions, where the identification of the different phenotypes is of an utmost importance in modelling immune response. While expressed markers are the most used signature to classify phenotypes, multiple reports indicate that macrophage morphology and autofluorescence are also valuable clues that can be used in the identification process. In this work, we investigated macrophage autofluorescence as a distinct feature for classifying six different macrophage phenotypes, namely: M0, M1, M2a, M2b, M2c, and M2d. The identification was based on extracted signals from multi-channel/multi-wavelength flow cytometer. To achieve the identification, we constructed a dataset containing 152,438 cell events each having a response vector of 45 optical signals fingerprint. Based on this dataset, we applied different supervised machine learning methods to detect phenotype specific fingerprint from the response vector, where the fully connected neural network architecture provided the highest classification accuracy of 75.8% for the six phenotypes compared simultaneously. Furthermore, by restricting the number of phenotypes in the experiment, the proposed framework produces higher classification accuracies, averaging 92.0%, 91.9%, 84.2%, and 80.4% for a pool of two, three, four, five phenotypes, respectively. These results indicate the potential of the intrinsic autofluorescence for classifying macrophage phenotypes, with the proposed method being quick, simple, and cost-effective way to accelerate the discovery of macrophage phenotypical diversity.

Identifiants

pubmed: 36997576
doi: 10.1038/s41598-023-32158-7
pii: 10.1038/s41598-023-32158-7
pmc: PMC10061362
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5202

Informations de copyright

© 2023. The Author(s).

Références

Front Immunol. 2014 Oct 07;5:491
pubmed: 25339958
J Leukoc Biol. 2013 Jul;94(1):193-202
pubmed: 23667167
Nat Biomed Eng. 2021 Jan;5(1):77-88
pubmed: 32719514
Biomed Res Int. 2016;2016:9582430
pubmed: 27493969
Front Syst Neurosci. 2021 Jan 15;14:615129
pubmed: 33519390
Cytometry A. 2022 Nov;101(11):922-941
pubmed: 35349225
Lab Invest. 1994 Nov;71(5):737-44
pubmed: 7967525
Front Immunol. 2022 Jan 03;12:787574
pubmed: 35046945
J Clin Invest. 2012 Mar;122(3):787-95
pubmed: 22378047
Nat Protoc. 2016 Apr;11(4):664-87
pubmed: 26963630
Eur J Cancer. 2006 Apr;42(6):717-27
pubmed: 16520032
Adv Drug Deliv Rev. 2014 May;71:15-33
pubmed: 24530633
Sci Rep. 2016 Mar 15;6:21471
pubmed: 26975219
Nat Commun. 2021 May 10;12(1):2614
pubmed: 33972525
Nat Rev Mol Cell Biol. 2022 Jan;23(1):40-55
pubmed: 34518686
Int J Mol Sci. 2018 Jun 19;19(6):
pubmed: 29921749
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32785653
Immunobiology. 2014 Sep;219(9):695-703
pubmed: 24916404
Chem Sci. 2020 Jul 22;11(31):8231-8239
pubmed: 34123093
PLoS One. 2014 Mar 21;9(3):e92564
pubmed: 24658436
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17253-8
pubmed: 24101477
PLoS One. 2014 Apr 15;9(4):e94188
pubmed: 24736635
Front Immunol. 2018 Sep 07;9:1930
pubmed: 30245686
Sci Rep. 2019 Jul 31;9(1):11088
pubmed: 31366998
Semin Immunol. 2021 Apr;54:101523
pubmed: 34776300
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
Front Immunol. 2018 Jun 07;9:888
pubmed: 29930549
Front Immunol. 2014 Oct 27;5:532
pubmed: 25386178
J Leukoc Biol. 2002 Jul;72(1):101-6
pubmed: 12101268
Curr Protoc Immunol. 2018 Feb 21;120:5.1.1-5.1.11
pubmed: 29512141
J Zhejiang Univ Sci B. 2022 May 15;23(5):407-422
pubmed: 35557041
J Leukoc Biol. 2013 Jun;93(6):875-81
pubmed: 23505314
J Histochem Cytochem. 1979 Jan;27(1):36-43
pubmed: 220325
Infect Immun. 2014 Oct;82(10):4190-203
pubmed: 25047849
Theranostics. 2020 Feb 3;10(7):2897-2917
pubmed: 32194843
Blood. 2007 Dec 15;110(13):4319-30
pubmed: 17848619
Nat Rev Immunol. 2020 Jul;20(7):448
pubmed: 32488203
JCI Insight. 2016;1(2):
pubmed: 26973881
Biotechnol Annu Rev. 2005;11:227-56
pubmed: 16216779
Front Biosci. 2008 Jan 01;13:453-61
pubmed: 17981560
J Leukoc Biol. 2019 Aug;106(2):345-358
pubmed: 30576000
Sci Rep. 2017 Jun 14;7(1):3521
pubmed: 28615717
Anal Methods. 2021 Feb 28;13(8):1019-1032
pubmed: 33538723
Atherosclerosis. 2019 Jun;285:120-127
pubmed: 31051415
Immunity. 2014 Feb 20;40(2):274-88
pubmed: 24530056
Immunity. 2014 Jul 17;41(1):14-20
pubmed: 25035950
Front Bioeng Biotechnol. 2021 Apr 20;9:644648
pubmed: 33959597
Cell Rep Methods. 2021 Oct 25;1(6):100094
pubmed: 35474892
Cancer Res. 2009 Jun 1;69(11):4911-7
pubmed: 19458079
Curr Protoc Immunol. 2008 Nov;Chapter 14:14.2.1-14.2.8
pubmed: 19016446
Ann Hematol. 2020 Mar;99(3):431-441
pubmed: 32006153
Biomed Opt Express. 2013 Aug 12;4(9):1618-25
pubmed: 24049682
Nat Biomed Eng. 2019 Jun;3(6):466-477
pubmed: 31142829
Lung. 2015 Dec;193(6):947-53
pubmed: 26319657
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2676-E2685
pubmed: 29511099
BMC Infect Dis. 2018 Nov 15;18(1):576
pubmed: 30442123
Cell Res. 2010 Jun;20(6):701-12
pubmed: 20386569
Immunity. 2016 Mar 15;44(3):450-462
pubmed: 26982353
Front Oncol. 2021 Dec 20;11:788365
pubmed: 34988021
BMC Neurosci. 2022 Mar 31;23(1):21
pubmed: 35361108
J Fluoresc. 2020 Dec;30(6):1483-1489
pubmed: 32870453
Pharmacogenomics J. 2010 Aug;10(4):292-309
pubmed: 20676068
Brief Bioinform. 2004 Dec;5(4):328-38
pubmed: 15606969
Tumour Biol. 2018 Sep;40(9):1010428318797880
pubmed: 30183516
Front Immunol. 2018 Jun 14;9:1364
pubmed: 29963056

Auteurs

Tetiana Hourani (T)

Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, 3050, Australia.

Alexis Perez-Gonzalez (A)

Melbourne Cytometry Platform, Department of Microbiology and Immunology, The University of Melbourne, at The Peter Doherty Institute of Infection and Immunity, Parkville, VIC, 3010, Australia.

Khashayar Khoshmanesh (K)

School of Engineering, RMIT University, Melbourne, Victoria, 3000, Australia.

Rodney Luwor (R)

Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, 3050, Australia.
Fiona Elsey Cancer Research Institute, Ballarat, Victoria, 3350, Australia.
Federation University Australia, Ballarat, Victoria, 3350, Australia.

Adrian A Achuthan (AA)

Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, 3050, Australia.

Sara Baratchi (S)

School of Health & Biomedical Sciences, RMIT University, Bundoora, Victoria, 3083, Australia.

Neil M O'Brien-Simpson (NM)

ACTV Research Group, Division of Basic and Clinical Oral Sciences, Centre for Oral Health Research, Melbourne Dental School, Royal Dental Hospital, The University of Melbourne, 720 Swanston Street, Carlton, VIC, 3010, Australia.

Akram Al-Hourani (A)

School of Engineering, RMIT University, Melbourne, Victoria, 3000, Australia. akram.hourani@rmit.edu.au.

Articles similaires

Exploring blood-brain barrier passage using atomic weighted vector and machine learning.

Yoan Martínez-López, Paulina Phoobane, Yanaima Jauriga et al.
1.00
Blood-Brain Barrier Machine Learning Humans Support Vector Machine Software

Understanding the role of machine learning in predicting progression of osteoarthritis.

Simone Castagno, Benjamin Gompels, Estelle Strangmark et al.
1.00
Humans Disease Progression Machine Learning Osteoarthritis
Animals Natural Killer T-Cells Mice Adipose Tissue Lipid Metabolism
Humans Artificial Intelligence Neoplasms Prognosis Image Processing, Computer-Assisted

Classifications MeSH